Also known as “broken-heart syndrome,” Takotsubo syndrome is a stress-induced cardiomyopathy.
Findings of the TIPS-2 study, announced at the recent 2012 World Congress of Cardiology, put the promise of the polypill—a simplified, one-size-fits-all approach to prevention of cardiovascular morbidity—back on the table for international discussion. Here, Dr Christopher Cannon puts the TIPS-2 results in perspective.
The elderly patient has had type 2 diabetes for 15 years is now home bound after a stroke. Her HbA1c is 9.6 and she takes only metformin. Review the rest of her laboratory results and propose a management plan.
Would you treat the elevated A1C aggressively—and what would your target level be? Would you consider statins? Dr Shahady invites your insights.
Are these findings another green light for dark chocolate? Some experts say “yes” as they also point to a recommended upper daily “dose.” What does this new research add to the current data on the health benefits of the flavinoid-rich sweet? Drs Payal Kohli and Christopher Cannon discuss study results and what you should tell your patients.
There’s a new way to lower LDL cholesterol levels—by approximately 60% to 80%. Studies unveiled at the 2012 ACC meeting found that an injectable monoclonal antibody, when added to statin therapy cuts LDL cholesterol levels far in excess of what can be achieved with statin therapy alone. Drs Christopher Cannon and Payal Kohli discuss.
Patients with type 2 diabetes should be receiving statin therapy, but many patients who would benefit from these agents are not taking them—and not reaching target lipid levels. A recent study shows that timing of statin initiation can make a difference. Here to put the issue into perspective are Drs Christopher Cannon and Payal Kohli.
Do you consider an LDL of 100 and a non-HDL of 150 significant? What is your diagnosis? Would you consider medication in addition to recommending lifestyle changes? Answers to these quiz questions here.
A 47-year-old man sees you for a check-up. He complains only of low energy and attributes it to recent weight gain. But, there is much more.
Is it possible to imagine the practice of cardiovascular medicine today without the use of statin medications? Here, a concise review of the key studies that have proven the efficacy and long-term safety of this remarkable class of drugs.